Hyperphosphatemia in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study.
Bleyer
Anthony J
AJ
D000085:Acetates / Q000627:therapeutic use*; D017610:Calcium Compounds / Q000627:therapeutic use; D002614:Chelating Agents / Q000627:therapeutic use*; D006801:Humans; D054559:Hyperphosphatemia / Q000517:prevention & control*; D011073:Polyamines / Q000627:therapeutic use*; D000069603:Sevelamer
D000085:Acetates; D017610:Calcium Compounds; D002614:Chelating Agents; D011073:Polyamines; D000069603:Sevelamer; C120662:calcium acetate